ValiRx plc (LON:VAL – Get Free Report) rose 5.6% during trading on Monday . The stock traded as high as GBX 0.36 and last traded at GBX 0.36. Approximately 13,996,284 shares were traded during trading, an increase of 95% from the average daily volume of 7,178,194 shares. The stock had previously closed at GBX 0.34.
ValiRx Price Performance
The business’s fifty day moving average price is GBX 0.37 and its 200 day moving average price is GBX 0.52. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.65 and a quick ratio of 1.27. The stock has a market cap of £2.60 million, a P/E ratio of -0.38 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last issued its quarterly earnings data on Monday, September 29th. The company reported GBX (0.22) EPS for the quarter. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%. Sell-side analysts forecast that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- The How And Why of Investing in Oil Stocks
- Rivian’s Autonomy Bombshell Changes Everything—Even Its Valuation
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Financial Sector Breaks Out as Capital Rotates and Leadership Shifts
- NYSE Stocks Give Investors a Variety of Quality Options
- Super Micro’s Sell-Off Is a Mirage—Here’s Why the Rally May Come Back Fast
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
